Tomoyuki Kawaguchi
Overview
Explore the profile of Tomoyuki Kawaguchi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
78
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kagemoto K, Okamoto K, Okada Y, Sei M, Fujimoto S, Yagi M, et al.
DEN Open
. 2025 Jan;
5(1):e70051.
PMID: 39758158
Objectives: Recently, various endoscopic treatments for colorectal polyps have been reported, including cold snare polypectomy (CSP) and underwater endoscopic mucosal resection (UEMR), in addition to EMR. However, a precise treatment...
2.
Sogabe M, Okahisa T, Kagawa M, Kashihara T, Fujmoto S, Kawaguchi T, et al.
Sci Rep
. 2024 Sep;
14(1):22446.
PMID: 39341964
The influence of metabolic dysfunction-associated steatotic liver disease (MASLD) on gallbladder polyp development in both sexes remains elusive. Therefore, to clarify the role of MASLD in gallbladder polyp development, we...
3.
Sogabe M, Okahisa T, Kagawa M, Kashihara T, Shinomiya R, Miyake T, et al.
Aliment Pharmacol Ther
. 2024 Sep;
60(11-12):1587-1598.
PMID: 39310953
Background: The relationships between alcohol consumption, cardiometabolic factors, and liver fibrosis in patients with metabolic dysfunction-associated steatotic liver disease and those with metabolic dysfunction and alcohol-associated liver disease remain unclear....
4.
Shinomiya R, Sato Y, Yoshimoto T, Kawaguchi T, Hirao A, Okamoto K, et al.
Int Cancer Conf J
. 2024 Jul;
13(3):240-244.
PMID: 38962030
Comprehensive genome profiling (CGP) is expected to widen the scope of cancer drug options by identifying the genes involved in carcinogenesis. However, a few patients can access recommended treatments following...
5.
Sogabe M, Okahisa T, Kagawa M, Kashihara T, Fujmoto S, Kawaguchi T, et al.
Eur J Clin Invest
. 2024 Apr;
54(9):e14221.
PMID: 38634705
Background: The influence of alcohol intake on metabolic dysfunction-associated fatty liver disease (MAFLD) development and remission remains unclear; thus, we aimed to investigate their longitudinal associations. Methods: This observational cohort...
6.
Du Y, Kobashigawa Y, Okazaki K, Ogawa M, Kawaguchi T, Sato T, et al.
J Biochem
. 2024 Mar;
176(1):69-80.
PMID: 38471515
Schistosoma japonicum glutathione-S-transferase (SjGST), the so-called GST-tag, is one of the most widely used protein tags for the purification of recombinant proteins by affinity chromatography. Attachment of SjGST enables the...
7.
Okamoto K, Kawaguchi T, Kagemoto K, Kida Y, Mitsui Y, Nakamura F, et al.
Gastric Cancer
. 2024 Feb;
27(3):635-640.
PMID: 38407681
A 44-year-old woman with gastric cancer (GC) and fundic gland polyposis (FGPs) was referred to our hospital for further diagnosis and treatment. She successfully underwent eradication therapy for Helicobacter pylori...
8.
Kawaguchi T, Okamoto K, Fujimoto S, Bando M, Wada H, Miyamoto H, et al.
J Gastroenterol
. 2023 Nov;
59(1):11-23.
PMID: 37989907
Background: Although the serrated-neoplasia pathway reportedly accounts for 15-30% of colorectal cancer (CRC), no studies on chemoprevention of sessile serrated lesions (SSLs) have been reported. We searched for effective compounds...
9.
Okamoto K, Kawaguchi T, Kagemoto K, Kida Y, Mitsui Y, Sato Y, et al.
Endoscopy
. 2023 Aug;
55(S 01):E965-E966.
PMID: 37604451
No abstract available.
10.
Sato Y, Okamoto K, Kawano Y, Kasai A, Kawaguchi T, Sagawa T, et al.
J Clin Med
. 2023 Jul;
12(14).
PMID: 37510761
Gastric cancer is a heterogeneous disease with diverse histological and genomic subtypes, making it difficult to demonstrate treatment efficacy in clinical trials. However, recent efforts have been made to identify...